SCHEMBL4873203

SCHEMBL4873203

CNSO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22943001 0.70
Dimethylamine SCHEMBL21980951 0.60
SCHEMBL10154472 0.59
SCHEMBL6696653 0.59
SCHEMBL24539467 0.56
Hydrochloric Acid SCHEMBL5083086 0.56
SCHEMBL23052832 0.56
SCHEMBL14854095 0.56
SCHEMBL15865599 0.56
SCHEMBL24760966 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170197986-A1 DIHYDROPYRIMIDO LOOP DERIVATIVE AS HBV INHIBITOR MEDSHINE DISCOVERY INC. (CN) 2017-07-13 US disclosed
WO-2009076166-A2 OXIMYL HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-06-18 WO disclosed
WO-2009073780-A1 PROCESS FOR MAKING MACROCYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-06-11 WO disclosed
US-20080036373-A1 Platinum complex and light-emitting device TAKASAGO INTERNATIONAL CORPORATION 2008-02-14 US disclosed
WO-2007146695-A1 ACYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2007-12-21 WO disclosed
WO-2007115966-A1 HETEROCYCLIC GABA ALPHA SUBTYPE SELECTIVE RECEPTOR MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2007-10-18 WO disclosed
US-20060202197-A1 Platinum complex and light-emitting device TAKASAGO INTERNATIONAL CORPORATION 2006-09-14 US disclosed
US-5451564-A And oxy-phosporus compound ZENECA LIMITED (GB) 1995-09-19 US disclosed
EP-0500352-A1 Biocidal compositions containing oxy-phosphorous compounds to enhance solubility ZENECA LIMITED (GB) 1992-08-26 EP disclosed